Labcorp Holdings Diagnostics — Supplies Expense increased by 4.0% to $613.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.6%, from $586.60M to $613.50M. Over 3 years (FY 2022 to FY 2025), Diagnostics — Supplies Expense shows an upward trend with a 7.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in supplies expense as a percentage of revenue may indicate rising input costs or supply chain inefficiencies, while a decrease suggests better procurement or economies of scale.
This represents the costs associated with consumables, reagents, testing kits, and other materials required to perform d...
Standard variable cost metric for laboratory and medical testing companies.
lh_segment_diagnostics_supplies_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $478.68M | $478.68M | $478.68M | $478.68M | $516.50M | $516.50M | $516.50M | $516.50M | $560.40M | $544.30M | $538.10M | $566.80M | $586.60M | $591.30M | $589.40M | $589.70M | $613.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.9% | +0.0% | +0.0% | +0.0% | +8.5% | -2.9% | -1.1% | +5.3% | +3.5% | +0.8% | -0.3% | +0.1% | +4.0% |
| YoY Change | — | — | — | — | +7.9% | +7.9% | +7.9% | +7.9% | +8.5% | +5.4% | +4.2% | +9.7% | +4.7% | +8.6% | +9.5% | +4.0% | +4.6% |